Study of Palifosfamide-tris in Combination With Doxorubicin in Patients With Front-line Metastatic Soft Tissue Sarcoma

Completed · Phase 3 · Has a placebo group

Conditions studied: Soft Tissue Sarcoma

In brief

This is an international, randomized, double-blind, placebo-controlled trial to evaluate the clinical efficacy of palifosfamide-tris administered with doxorubicin in combination, compared with doxorubicin administered with placebo in front-line patients diagnosed with metastatic soft tissue sarcoma (STS).

Key facts

Study ID

NCT01168791

Run by

Alaunos Therapeutics

People needed

447

Starts

2010-07-01

Expected to finish

2013-03-01

Last updated by the study team

2013-07-18

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Arizona Oncology Associates — Phoenix, Arizona, United States
• Study site — Scottsdale, Arizona, United States
• Arizona Cancer Center — Tucson, Arizona, United States
• University of Arkansas for Medical Sciences — Little Rock, Arkansas, United States
• University of California, Los Angeles — Los Angeles, California, United States
• Study site — Los Angeles, California, United States
• University of California, Irvine — Orange, California, United States
• Study site — Pomona, California, United States
• Sarcoma Oncology Center — Santa Monica, California, United States
• University of Colorado Cancer Center — Aurora, Colorado, United States
• Rocky Mountain Cancer Centers — Denver, Colorado, United States
• Medical Oncology Hematology Consultants — Newark, Delaware, United States
• MedStar Research Institute — Washington D.C., District of Columbia, United States
• Study site — Washington D.C., District of Columbia, United States
• Study site — Jacksonville, Florida, United States
• Study site — Orlando, Florida, United States
• Moffitt Cancer Center — Tampa, Florida, United States
• Palm Beach Cancer Institute — West Palm Beach, Florida, United States
• Emory — Atlanta, Georgia, United States
• Medical College of Georgia — Augusta, Georgia, United States
• Kootenai Cancer Center — Post Falls, Idaho, United States
• Study site — Chicago, Illinois, United States
• Study site — Park Ridge, Illinois, United States
• Indiana University Simon Cancer Center — Indiannapolis, Indiana, United States
• Study site — Birmingham, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.